Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies
Investigative Opthalmology & Visual Science · 07.02.2024 · 65 (2) · 16
DOI: 10.1167/iovs.65.2.16 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Investigative Opthalmology & Visual Science, erschienen am 07.02.2024. Verfasst von Richard Kontoh-Twumasi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, Georgia, United States. Hauptthemen laut MEDLINE: Eye Diseases, Serpins. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NEI NIH HHS.
Abstract (Originalsprache)
Serine protease inhibitors A1 (SerpinA1) and A3 (SerpinA3) are important members of the serpin family, playing crucial roles in the regulation of serine proteases and influencing various physiological processes. SerpinA1, also known as α-1-antitrypsin, is a versatile glycoprotein predominantly synthesized in the liver, with additional production in inflammatory and epithelial cell types. It exhibits multifaceted functions, including immune modulation, complement activation regulation, and inhibition of endothelial cell apoptosis. SerpinA3, also known as α-1-antichymotrypsin, is expressed both extracellularly and intracellularly in various tissues, particularly in the retina, kidney, liver, and pancreas. It exerts anti-inflammatory, anti-angiogenic, antioxidant, and antifibrotic activities. Both SerpinA1 and SerpinA3 have been implicated in conditions such as keratitis, diabetic retinopathy, age-related macular degeneration, glaucoma, cataracts, dry eye disease, keratoconus, uveitis, and pterygium. Their role in influencing metalloproteinases and cytokines, as well as endothelial permeability, and their protective effects on Müller cells against oxidative stress further highlight their diverse and critical roles in ocular pathologies. This review provides a comprehensive overview of the etiology and functions of SerpinA1 and SerpinA3 in ocular diseases, emphasizing their multifaceted roles and the complexity of their interactions within the ocular microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, Georgia, United States.
- Morsani College of Medicine, University of South Florida, Tampa, Florida, United States.
- Department of Ophthalmology, Augusta University, Augusta, Georgia, United States.
Förderung
- NEI NIH HHS
Zitieren
APA
Kontoh-Twumasi, R., Budkin, S., Edupuganti, N., Vashishtha, A., & Sharma, S. (2024). Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies. Investigative Opthalmology & Visual Science, 65(2), 16. https://doi.org/10.1167/iovs.65.2.16
Vancouver
Kontoh-Twumasi R, Budkin S, Edupuganti N, Vashishtha A, Sharma S. Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies. Investigative Opthalmology & Visual Science. 2024;65(2):16. doi:10.1167/iovs.65.2.16
BibTeX
@article{KontohTwumasi2024,
author = {Kontoh-Twumasi, Richard and Budkin, Stepan and Edupuganti, Neel and Vashishtha, Ayushi and Sharma, Shruti},
title = {Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
volume = {65},
number = {2},
pages = {16},
doi = {10.1167/iovs.65.2.16}
}
EUVIMED